Pharmaceutics, Volume 15, Issue 9
2023 September - 194 articles
Cover Story: Lipid nanoparticles (LNPs) have shown great promise for mRNA delivery, but challenges such as toxicity and immunogenicity remain to be addressed. This study aimed to compare the performances of polyplex nanomicelles, an original cationic polymer-based carrier, and LNPs, in regard to various aspects including delivery efficiency, organ toxicity, muscle damage, immune reaction, and pain. The authors showed the distinct characteristics of nanomicelles and LNPs (SM-102), with the former demonstrating relatively sustained protein production and reduced inflammation, making them suitable for therapeutic purposes. Meanwhile, LNPs displayed desirable properties for vaccines, such as rapid mRNA expression and a potent immune response. These results support the further optimization of mRNA delivery systems tailored for specific purposes. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.